Large-scale genotyping identifies 41 new loci associated with breast cancer risk

Nature Genetics

Volumn 45, Issue 4, 2013, Pages 353-361

  Michailidou, Kyriaki ^a,cu   Hall, Per ^b,cu   Gonzalez Neira, Anna ^c   Ghoussaini, Maya ^a   Dennis, Joe ^a   Milne, Roger L ^c   Schmidt, Marjanka K ^d   Chang Claude, Jenny ^e   Bojesen, Stig E ^f,g   Bolla, Manjeet K ^a   Wang, Qin ^a   Dicks, Ed ^a   Lee, Andrew ^a   Turnbull, Clare ^h   Rahman, Nazneen ^h   Fletcher, Olivia ⁱ   Peto, Julian ^h   Gibson, Lorna ^h   Dos Santos Silva, Isabel ^h   Nevanlinna, Heli ^j   Muranen, Taru A ^j   Aittomäki, Kristiina ^k   Blomqvist, Carl ^k   Czene, Kamila ^b   Irwanto, Astrid ^k   Liu, Jianjun ^k   Waisfisz, Quinten ^l   Meijers Heijboer, Hanne ^l   Adank, Muriel ^l   Van Der Luijt, Rob B ^m   Hein, Rebecca ^e,n   Dahmen, Norbert ^o   Beckman, Lars ^p   Meindl, Alfons ^q   Schmutzler, Rita K ^o,r   Müller Myhsok, Bertram ^o   Lichtner, Peter ^s   Hopper, John L ^t   Southey, Melissa C ^u   Makalic, Enes ^t   Schmidt, Daniel F ^t   Uitterlinden, Andre G ^v   Hofman, Albert ^w   Hunter, David J ^w   Chanock, Stephen J ^x   Vincent, Daniel ^y   Bacot, François ^y   Tessier, Daniel C ^y   Canisius, Sander ^z   Wessels, Lodewyk F A ^z   Haiman, Christopher A ^d   Shah, Mitul ^a   Luben, Robert ^a   Brown, Judith ^a   Luccarini, Craig ^a   Schoof, Nils ^b   Humphreys, Keith ^b   Li, Jingmei ^k   Nordestgaard, Børge G ^f,g   Nielsen, Sune F ^f,g   Flyger, Henrik ^aa   Couch, Fergus J ^g   Wang, Xianshu ^g   Vachon, Celine ^ab   Stevens, Kristen N ^ab   Lambrechts, Diether ^ab,ac   Moisse, Matthieu ^ab,ac   Paridaens, Robert ^ad   Christiaens, Marie Rose ^ad   Rudolph, Anja ^e   Nickels, Stefan ^e   Flesch Janys, Dieter ^e,ae,af   Johnson, Nichola ⁱ   Aitken, Zoe ^h   Aaltonen, Kirsimari ^j,k   Heikkinen, Tuomas ^j   Broeks, Annegien ^d   Veer, Laura J Van'T ^d   Van Der Schoot, C Ellen ^af   Guénel, Pascal ^ag,ah   Truong, Thérèse ^ag,ah   Laurent Puig, Pierre ^ai   Menegaux, Florence ^ag,ah   Marme, Frederik ^aj,ak   Schneeweiss, Andreas ^aj,ak   Sohn, Christof ^aj   Burwinkel, Barbara ^aj,ak   Zamora, M Pilar ^e   Perez, Jose Ignacio Arias ^al   Pita, Guillermo ^c   Alonso, M Rosario ^c   Cox, Angela ^am   Brock, Ian W ^am   Cross, Simon S ^an   Reed, Malcolm W R ^am   Sawyer, Elinor J ^an   Tomlinson, Ian ^ao,ap   Kerin, Michael J ^aq   Miller, Nicola ^aq   Henderson, Brian E ^d   Schumacher, Fredrick ^d   Le Marchand, Loic ^ar   Andrulis, Irene L ^as,at   Knight, Julia A ^at,au   Glendon, Gord ^as   Mulligan, Anna Marie ^au,av   Lindblom, Annika ^aw   Margolin, Sara ^b   Hooning, Maartje J ^b   Hollestelle, Antoinette ^b   Van Den Ouweland, Ans M W ^w   Jager, Agnes ^b   Bui, Quang M ^t   Stone, Jennifer ^t   Dite, Gillian S ^t   Apicella, Carmel ^t   Tsimiklis, Helen ^u   Giles, Graham G ^t,w   Severi, Gianluca ^t,w   Baglietto, Laura ^t,w   Fasching, Peter A ^ax,ay   Haeberle, Lothar ^ax   Ekici, Arif B ^az   Beckmann, Matthias W ^ax   Brenner, Hermann ^ba   Müller, Heiko ^ba   Arndt, Volker ^ba   Stegmaier, Christa ^e   Swerdlow, Anthony ^h   Ashworth, Alan ^i,bb   Orr, Nick ^i,bb   Jones, Michael ^h   Figueroa, Jonine ^x   Lissowska, Jolanta ^h   Brinton, Louise ^x   Goldberg, Mark S ^z,bc   Labrèche, France ^bd   Dumont, Martine ^be   Winqvist, Robert ^bf   Pylkäs, Katri ^bf   Jukkola Vuorinen, Arja ^bg   Grip, Mervi ^bh   Brauch, Hiltrud ^bh,bi   Hamann, Ute ^bj   Brüning, Thomas ^e   Radice, Paolo ^bk,bl   Peterlongo, Paolo ^bk,bl   Manoukian, Siranoush ^bm   Bonanni, Bernardo ^bn   Devilee, Peter ^bo,bp   Tollenaar, Rob A E M ^bp   Seynaeve, Caroline ^bp   Van Asperen, Christi J ^w   Jakubowska, Anna ^bp   Lubinski, Jan ^bp   Jaworska, Katarzyna ^bp,bq   Durda, Katarzyna ^bp   Mannermaa, Arto ^br,bs   Kataja, Vesa ^bs,bt   Kosma, Veli Matti ^br,bs   Hartikainen, Jaana M ^br,bs   Bogdanova, Natalia V ^bt,bu   Antonenkova, Natalia N ^bu   Dörk, Thilo ^bt   Kristensen, Vessela N ^bv,bw   Anton Culver, Hoda ^bx   Slager, Susan ^ab   Toland, Amanda E ^by   Edge, Stephen ^bz   Fostira, Florentia ^ca   Kang, Daehee ^cb   Yoo, Keun Young ^cb   Noh, Dong Young ^cb   Matsuo, Keitaro ^cc   Ito, Hidemi ^cc   Iwata, Hiroji ^cd   Sueta, Aiko ^cc   Wu, Anna H ^d   Tseng, Chiu Chen ^d   Van Den Berg, David ^d   Stram, Daniel O ^d   Shu, Xiao Ou ^cd   Lu, Wei ^ce   Gao, Yu Tang ^cf   Cai, Hui ^cd   Teo, Soo Hwang ^cg,ch   Yip, Cheng Har ^ch   Phuah, Sze Yee ^cg   Cornes, Belinda K ^ci   Hartman, Mikael ^cj   Miao, Hui ^cj   Lim, Wei Yen ^cj   Sng, Jen Hwei ^cj   Muir, Kenneth ^ck   Lophatananon, Artitaya ^ck   Stewart Brown, Sarah ^ck   Siriwanarangsan, Pornthep ^cl   Shen, Chen Yang ^cm,cn   Hsiung, Chia Ni ^cm   Wu, Pei Ei ^co   Ding, Shian Ling ^cn   Sangrajrang, Suleeporn ^cp   Gaborieau, Valerie ^cq   Brennan, Paul ^cq   McKay, James ^cq   Blot, William J ^cd,cr   Signorello, Lisa B ^cd,cr   Cai, Qiuyin ^cd   Zheng, Wei ^cd   Deming Halverson, Sandra ^cd   Shrubsole, Martha ^cd   Long, Jirong ^cd   Simard, Jacques ^be   Garcia Closas, Montse ^h,i,bb   Pharoah, Paul D P ^a   Chenevix Trench, Georgia ^cs   Dunning, Alison M ^a   Benitez, Javier ^c,ct   Easton, Douglas F ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ Institute of Cancer Research ^*  (United Kingdom)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^k UNIVERSITY OF HELSINKI   (Finland)

^l GENOME INSTITUTE OF SINGAPORE   (Singapore)

^m VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^o UNIVERSITY OF COLOGNE   (Germany)

^p JOHANNES GUTENBERG UNIVERSITY   (Germany)

^q INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

^r TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^s MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^t INSTITUTE OF EPIDEMIOLOGY   (Germany)

^u UNIVERSITY OF MELBOURNE   (Australia)

^v UNIVERSITY OF MELBOURNE   (Australia)

^w ERASMUS MEDICAL CENTER   (Netherlands)

^x HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^y NATIONAL CANCER INSTITUTE   (United States)

^z MCGILL UNIVERSITY   (Canada)

^aa UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ab MAYO CLINIC   (United States)

^ac DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^ad UNIVERSITY OF LEUVEN   (Belgium)

^ae UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^af UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^ag SANQUIN RESEARCH   (Netherlands)

^ah NATIONAL INSTITUTES OF HEALTH   (United States)

^ai CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^aj INSERM   (France)

^ak UNIVERSITY OF HEIDELBERG   (Germany)

^al HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^am HOSPITAL MONTE NARANCO   (Spain)

^an UNIVERSITY OF SHEFFIELD   (United Kingdom)

^ao GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^ap UNIVERSITY OF OXFORD   (United Kingdom)

^aq UNIVERSITY OF OXFORD   (United Kingdom)

^ar UNIVERSITY HOSPITAL GALWAY   (Ireland)

^as UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^at MOUNT SINAI HOSPITAL   (Canada)

^au UNIVERSITY OF TORONTO   (Canada)

^av UNIVERSITY OF TORONTO   (Canada)

^aw UNIVERSITY HEALTH NETWORK   (Canada)

^ax CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ay UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^az UNIVERSITY OF CALIFORNIA   (United States)

^ba UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^bb SAARLAND CANCER REGISTRY   (Germany)

^bc INSTITUTE OF ONCOLOGY   (Poland)

^bd ROYAL VICTORIA HOSPITAL   (Canada)

^be UNIVERSITÉ DE MONTRÉAL   (Canada)

^bf LAVAL UNIVERSITY   (Canada)

^bg UNIVERSITY OF OULU   (Finland)

^bh OULU UNIVERSITY HOSPITAL   (Finland)

^bi DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^bj UNIVERSITY OF TÜBINGEN   (Germany)

^bk RUHR UNIVERSITY BOCHUM   (Germany)

^bl NATIONAL CANCER INSTITUTE   (Italy)

^bm FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^bn IRCCS   (Italy)

^bo EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^bp LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^bq POMERANIAN MEDICAL UNIVERSITY   (Poland)

^br MEDICAL UNIVERSITY OF WARSAW   (Poland)

^bs UNIVERSITY OF EASTERN FINLAND   (Finland)

^bt KUOPIO UNIVERSITY HOSPITAL   (Finland)

^bu HANNOVER MEDICAL SCHOOL   (Germany)

^bv Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

^bw UNIVERSITY OF OSLO   (Norway)

^bx OSLO UNIVERSITY HOSPITAL   (Norway)

^by UNIVERSITY OF CALIFORNIA   (United States)

^bz OHIO STATE UNIVERSITY   (United States)

^ca ROSWELL PARK CANCER INSTITUTE   (United States)

^cb INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^cc Seoul National University College of Medicine   (South Korea)

^cd AICHI CANCER CENTER HOSPITAL   (Japan)

^ce VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^cf Shanghai Center for Disease Control and Prevention   (China)

^cg SHANGHAI CANCER INSTITUTE   (China)

^ch CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^ci UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^cj NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^ck NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^cl UNIVERSITY OF WARWICK   (United Kingdom)

^cm MINISTRY OF PUBLIC HEALTH   (Thailand)

^cn INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^co CHINA MEDICAL UNIVERSITY   (Taiwan)

^cp Kang Ning Junior College of Medical Care and Management   (Taiwan)

^cq NATIONAL CANCER INSTITUTE   (Thailand)

^cr INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^cs INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^ct QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^cu CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CAUCASIAN; CHROMOSOME 16; DNA RECOMBINATION; FAMILY HISTORY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOMIC INSTABILITY; GENOTYPE; HAPLOTYPE MAP; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LYMPHOCYTE; OVARY CANCER; POPULATION STRUCTURE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON; TUMOR GROWTH; WNT SIGNALING PATHWAY;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; COOPERATIVE BEHAVIOR; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; META-ANALYSIS AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84875703379     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2563     Document Type: Article

References (68)

1. Kamangar, F., Dores, G.M. and Anderson, W.F. Patterns of cancer incidence, mortality, and prevalence across fve continents: defning priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 24, 2137-2150 (2006).
2. Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78-85 (2000).
3. Peto, J. and Mack, T.M. High constant incidence in twins and other relatives of women with breast cancer. Nat. Genet. 26, 411-414 (2000).
4. Easton, D.F. et al. Genome-wide association study identifes novel breast cancer susceptibility loci. Nature 447, 1087-1093 (2007).
5. Hunter, D.J. et al. A genome-wide association study identifes alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870-874 (2007).
6. Stacey, S.N. et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 39, 865-869 (2007).
7. Stacey, S.N. et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 40, 703-706 (2008).
8. Ahmed, S. et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat. Genet. 41, 585-590 (2009).
9. Zheng, W. et al. Genome-wide association study identifes a new breast cancer susceptibility locus at 6q25.1. Nat. Genet. 41, 324-328 (2009).
10. Thomas, G. et al. A multistage genome-wide association study in breast cancer identifes two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet. 41, 579-584 (2009).
11. Turnbull, C. et al. Genome-wide association study identifes fve new breast cancer susceptibility loci. Nat. Genet. 42, 504-507 (2010).
12. Antoniou, A.C. et al. A locus on 19p13 modifes risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat. Genet. 42, 885-892 (2010).
13. Fletcher, O. et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J. Natl. Cancer Inst. 103, 425-435 (2011).
14. Haiman, C.A. et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat. Genet. 43, 1210-1214 (2011).
15. Ghoussaini, M. et al. Genome-wide association analysis identifes three new breast cancer susceptibility loci. Nat. Genet. 44, 312-318 (2012).
16. Siddiq, A. et al. A meta-analysis of genome-wide association studies of breast cancer identifes two novel susceptibility loci at 6q14 and 20q11. Hum. Mol. Genet. 21, 5373-5384 (2012).
17. Eeles, R.A. et al. Identifcation of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat. Genet. published online; doi:10.1038/ng.2560 (27 March 2013).
18. Pharoah, P.D.P. et al. GWAS meta-analysis and replication identifes three new susceptibility loci for ovarian cancer. Nat. Genet. published online; doi:10.1038/ng.2564 (27 March 2013).
19. Couch, F.J. et al. Genome-wide association study in BRCA1 mutation carriers identifes novel loci associated with breast and ovarian cancer risk. PLoS Genet. 9, e1003212 (2013).
20. Gaudet, M.M. et al. Identifcation of a BRCA2-specifc modifer locus at 6p24 related to breast cancer risk. PLoS Genet. 9, e1003173 (2013).
21. Cox, A. et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 39, 352-358 (2007).
22. Turnbull, C. et al. Genome-wide association study identifes fve new breast cancer susceptibility loci. Nat. Genet. 42, 504-507 (2010).
23. Lambrechts, D. et al. 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum. Mutat. 33, 1123-1132 (2012).
24. Stevens, K.N. et al. 19p13.1 is a triple-negative-specifc breast cancer susceptibility locus. Cancer Res. 72, 1795-1803 (2012).
25. Antoniou, A.C. and Easton, D.F. Polygenic inheritance of breast cancer: implications for design of association studies. Genet. Epidemiol. 25, 190-202 (2003).
26. Figueroa, J.D. et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: fndings from the Breast Cancer Association Consortium. Hum. Mol. Genet. 20, 4693-4706 (2011).
27. Mazoyer, S. et al. A polymorphic stop codon in BRCA2. Nat. Genet. 14, 253-254 (1996).
28. Schutte, M. et al. Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility. Am. J. Hum. Genet. 72, 1023-1028 (2003).
29. Hemphill, A.W. et al. Mammalian SNM1 is required for genome stability. Mol. Genet. Metab. 94, 38-45 (2008).
30. Scollen, S. et al. TGF-β signaling pathway and breast cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 20, 1112-1119 (2011).
31. Ma, X. et al. Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians. Cancer Epidemiol. Biomarkers Prev. 21, 1176-1184 (2012).
32. Burwinkel, B. et al. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer 6, 268 (2006).
33. Goode, E.L. et al. A genome-wide association study identifes susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat. Genet. 42, 874-879 (2010).
34. Eeles, R.A. et al. Identifcation of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet. 41, 1116-1121 (2009).
35. Yang, T.P. et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 26, 2474-2476 (2010).
36. Shimozawa, N. et al. Identifcation of a new complementation group of the peroxisome biogenesis disorders and PEX14 as the mutated gene. Hum. Mutat. 23, 552-558 (2004).
37. Murfuni, I. et al. The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation. Oncogene 32, 610-620 (2013).
38. Pamidi, A. et al. Functional interplay of p53 and Mus81 in DNA damage responses and cancer. Cancer Res. 67, 8527-8535 (2007).
39. Leong, S., McKay, M.J., Christopherson, R.I. and Baxter, R.C. Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL. J. Proteome Res. 11, 1240-1250 (2012).
40. Wang, W. et al. The activity status of coflin is directly related to invasion, intravasation, and metastasis of mammary tumors. J. Cell Biol. 173, 395-404 (2006).
41. Dunbar, M.E., Wysolmerski, J.J. and Broadus, A.E. Parathyroid hormone-related protein: from hypercalcemia of malignancy to developmental regulatory molecule. Am. J. Med. Sci. 312, 287-294 (1996).
42. Dunbar, M.E. et al. Stromal cells are critical targets in the regulation of mammary ductal morphogenesis by parathyroid hormone-related protein. Dev. Biol. 203, 75-89 (1998).
43. Qiao, Y. et al. FOXQ1 regulates epithelial-mesenchymal transition in human cancers. Cancer Res. 71, 3076-3086 (2011).
44. Kaneda, H. et al. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer Res. 70, 2053-2063 (2010).
45. Debily, M.A. et al. Expression and molecular characterization of alternative transcripts of the ARHGEF5/TIM oncogene specifc for human breast cancer. Hum. Mol. Genet. 13, 323-334 (2004).
46. Muehlich, S. et al. The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1. Oncogene 31, 3913-3923 (2012).
47. Frayling, T.M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (2007).
48. Grant, S.F. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320-323 (2006).
49. Sladek, R. et al. A genome-wide association study identifes novel risk loci for type 2 diabetes. Nature 445, 881-885 (2007).
50. Jingushi, K. et al. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines. Biochem. Pharmacol. 83, 47-56 (2012).
51. Dantuma, N.P., Heinen, C. and Hoogstraten, D. The ubiquitin receptor Rad23: at the crossroads of nucleotide excision repair and proteasomal degradation. DNA Repair (Amst.) 8, 449-460 (2009).
52. Lee, J.C. et al. Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c-myb. Cell Biochem. Funct. 26, 892-899 (2008).
53. Castro, P., Liang, H., Liang, J.C. and Nagarajan, L. A novel, evolutionarily conserved gene family with putative sequence-specifc single-stranded DNA-binding activity. Genomics 80, 78-85 (2002).
54. Sanchez-Cespedes, M. et al. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res. 61, 1309-1313 (2001).
55. Nakamura, T. et al. Molecular cloning and characterization of Kremen, a novel kringle-containing transmembrane protein. Biochim. Biophys. Acta 1518, 63-72 (2001).
56. Nakamura, T., Nakamura, T. and Matsumoto, K. The functions and possible signifcance of Kremen as the gatekeeper of Wnt signalling in development and pathology. J. Cell Mol. Med. 12, 391-408 (2008).
57. Esseghir, S. et al. Identifcation of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins. Clin. Cancer Res. 13, 3164-3173 (2007).
58. Morris, A.P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981-990 (2012).
59. Ahmadiyeh, N. et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specifc long-range interaction with MYC. Proc. Natl. Acad. Sci. USA 107, 9742-9746 (2010).
60. Purcell, S.M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009).
61. French, J.D. et al. Functional variants at the 11q13 risk locus regulate cyclin D1 expression through long-range enhancers. Am. J. Hum. Genet. published online; 10.1016/j.ajhg.2013.01.002 (27 March 2013).
62. Bojesen, S.E. et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet. published online; doi:10.1038/ng.2566 (27 March 2013).
63. Aulchenko, Y.S., Struchalin, M.V. and van Duijn, C.M. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 11, 134 (2010).
64. Devlin, B. and Roeder, K. Genomic control for association studies. Biometrics 55, 997-1004 (1999).
65. Teo, Y.Y. et al. A genotype calling algorithm for the Illumina BeadArray platform. Bioinformatics 23, 2741-2746 (2007).
66. Giannoulatou, E., Yau, C., Colella, S., Ragoussis, J. and Holmes, C.C. GenoSNP: a variational Bayes within-sample SNP genotyping algorithm that does not require a reference population. Bioinformatics 24, 2209-2214 (2008).
67. Haldane, J.B.S. An exact test for randomness of mating. J. Genet. 52, 631-635 (1954).
68. Stranger, B.E. et al. Patterns of cis regulatory variation in diverse human populations. PLoS Genet. 8, e1002639 (2012).